For our study we have evaluated the detection of PD-1 on T cells using a basic four-color panel (CD45, CD8, PD1, and a live/dead marker) in a small dataset of 15 patients with ovarian cancer across different stages of treatment. Here, CD8A is linked to ovarian carcinoma.